5-Bromo-2-iodopyrimidine | CAS:183438-24-6

We serve 5-Bromo-2-iodopyrimidine CAS:183438-24-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Bromo-2-iodopyrimidine

Chemical Name:5-Bromo-2-iodopyrimidine
CAS.NO:183438-24-6
Synonyms:5-Bromo-2-iodopyrimidine
5-bromo-2-iodo-pyrimidine
5-Bromo-iodopyrimidine
2-iodine-5-bromopyrimidine
2-iodo-5-bromo-pyrimidine
 
Physical and Chemical Properties:
Density 2.5±0.1 g/cm3
Boiling Point 341.0±34.0 °C at 760 mmHg
Melting Point 99-103 °C(lit.)
Molecular Formula C4H2BrIN2
Molecular Weight 284.880
Flash Point 160.0±25.7 °C
 
Specification:
Appearance:White to light yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Macitentan(CAS:441798-33-0).



Contact us for information like 5-Bromo-2-iodopyrimidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-iodo-5-bromo-pyrimidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-iodine-5-bromopyrimidine Use and application,5-Bromo-2-iodopyrimidine technical grade,usp/ep/jp grade.


Related News: The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen’s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination.2,3-Difluorophenylboronic acid manufacturer Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media.2-(4-chlorophenyl)hexanenitrile supplier The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.3,5-Dibromo-2-methoxybenzenecarboxylic acid vendor That notice came two days after Chinese President Xi Jinping — a well known TCM advocate — called for the “combination of Chinese and Western medicine” in the diagnosis and treatment of the disease at a meeting of the Communist Party’s Politburo Standing Committee, the country’s supreme ruling body.The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.